Sachin Kamal‐Bahl

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004

Heli Ghandehari, Sachin Kamal‐Bahl, Nathan D. Wong · American Heart Journal · 2008 · 180 citations

Nutritional Epidemiology, Cardiovascular Epidemiology, Cardiovascular Disease +11

The Lifetime Medical Cost Burden of Overweight and Obesity: Implications for Obesity Prevention

Eric Finkelstein, Justin G. Trogdon, Derek S. Brown et al. · Obesity · 2008 · 173 citations

Obesity Prevention Efforts, Lifetime Costs, Financial Protection +21

Discontinuation of Lipid Modifying Drugs Among Commercially Insured United States Patients in Recent Clinical Practice

Sachin Kamal‐Bahl, Thomas Burke, Douglas J. Watson et al. · The American Journal of Cardiology · 2006 · 113 citations · Full text

Lipid Disorder, Health Policy, Health Insurance +8

Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis

Louis P. Garrison, Sachin Kamal‐Bahl, Adrian Towse · Value in Health · 2017 · 102 citations

Value Theory, Program Evaluation, Value Engineering +16

Abdominal obesity and the spectrum of global cardiometabolic risks in US adults

Heli Ghandehari, Sachin Kamal‐Bahl, Stanley Bassin et al. · International Journal of Obesity · 2008 · 94 citations

Obesity, Metabolic Syndrome, Global Cardiometabolic Risks +13